Shandong Announces Retail Price Caps For 33 Drugs, 13 Synthetic
This article was originally published in PharmAsia News
Shandong province’s commodity price bureau has newly announced retail price caps for 33 drugs, the majority of which common medicines, to be effective from Oct. 15.
You may also be interested in...
Phase Ib data at ASH look competitive with new pivotal trial results for Bristol/bluebird’s leading BCMA CAR-T bb2121. The Phase II portion of the CARTITUDE-1 study for JNJ-4528 is fully enrolled.
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.